Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LesScore: Lescol and Diovan for Cardiovascular Risk in Metabolic Syndrome
NCT00821574Phase 4Completed
- Sponsor
- Novartis
- Start
- Jul 2005
- Primary completion
- Mar 2007
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of fluvastatin, valsartan in metabolic syndrome, hypertension (HTN), dyslipidemia, sponsored by Novartis. Started Jul 2005; status: completed.
02
Drugs
fluvastatinvalsartan
03
Conditions
metabolic syndromehypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT00821574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00821574.